Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Justin Wahlstrom, MD
Pharmacyclics LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
102 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Kinghorn Cancer Centre /id# 1140-1165
Darlinghurst, New South Wales, Australia
- Westmead Hospital /id# 1140-0848
Westmead, New South Wales, Australia
- Royal Brisbane and Women'S Hospital /id# 1140-0190
Herston, Queensland, Australia
- Royal Children'S Hospital/id# 1140-1154
Parkville, Victoria, Australia
- Royal Melbourne Hospital (rmh) /id# 1140-0633
Parkville, Victoria, Australia
- Fiona Stanley Hospital /id# 1140-0880
Perth, Western Australia, Australia
- Univ. Klinik for Innere Medizin, Klinische Abteilung for Hematologie, Graz /id# 1140-0373
Graz, Austria
- Krankenhaus Der Elisabethinen Linz /id# 1140-0849
Linz, Austria
- University of British Columbia (ubc) - Vancouver General Hospital (vgh) /id# 1140-1166
Vancouver, British Columbia, Canada
- the Ottawa Hospital Regional Cancer Center /id# 1140-0159
Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre /id# 1140-0043
Toronto, Ontario, Canada
- Chu Sainte-Justine /id# 1140-1143
Montreal, Quebec, Canada
- the First Affiliated Hospital of Soochow University /id# 1140-1208
Suzhou, Jiangsu, China
- Chinese Pla General Hospital /id# 1140-1198
Beijing, China
- Nanfang Hospital /id# 1140-1379
Guangzhou, China
- Uhc Zagreb /id# 1140-1169
Zagreb, Croatia
- Hopital de Brabois /id# 1140-0775
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
- Hopital Saint-Louis - Institut Hematologie Centre Hayem Chu /id# 1140-0735
Paris, Île-de-France Region, France
- Chu Amiens Groupe Hospitalier Sud /id# 1140-1205
Amiens, France
- Chu de Grenoble Alpes /id# 1140-1058
Grenoble, France
- Centre Hospitalier Regional Universitaire de Lille /id# 1140-0750
Lille, France
- Chu de Nantes /id# 1140-0520
Nantes, France
- Groupe Hospitalier Pitie-Salpetriere /id# 1140-0918
Paris, France
- Robert Bosch Hospital /id# 1140-1160
Stuttgart, Baden-Wurttemberg, Germany
- Universitatsklinikum Munster /id# 1140-1195
Munster, Lower Saxony, Germany
- Universitaetsklinikum Dresden /id# 1140-1367
Dresden, Germany
- Hannover Medical School /id# 1140-1141
Hanover, Germany
- Dr. Haunerschen Kinderspital /id# 1140-1142
Munich, Germany
- University Hospital of Regensburg /id# 1140-1446
Regensburg, Germany
- St. Laszlo Hospital /id# 1140-1164
Budapest, Hungary
- Irccs Ospedale Pediatrico Bambino Gesu /id# 1140-1150
Rome, Lazio, Italy
- A.O. Univ. Ospedali Riuniti /id# 1140-0932
Ancona, The Marches, Italy
- Asst Papa Giovanni Xxiii /id# 1140-1231
Bergamo, Italy
- Ospedale San Raffaele Irccs /id# 1140-0523
Milan, Italy
- University of Torino /id# 1140-1268
Torino, Italy
- Centro Trapianti Cellule Staminali, Ospedale Infantile Regina Margherita /id# 1140-1156
Turin, Italy
- Anjou Kousei Hospital /id# 1140-1435
Anjo, Aichi-ken, Japan
- Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital /id# 1140-1437
Hiroshima, Hiroshima, Japan
- Kobe City Medical Center General Hospital /id# 1140-1438
Kobe, Hyōgo, Japan
- Hyogo College of Medicine College Hospital /id# 1140-1434
Nishinomiya-shi, Hyōgo, Japan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 May 2017
- Primary completion
- 27 Mar 2020
- Completion
- 12 Jul 2021
- Last update posted
- 30 Mar 2023
- Registered enrollment
- 193
- Registry id
- NCT02959944
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.